Why is the nanoscale special (or not)? Fundamental properties and how it relates to the design of nano-enabled drug delivery systems

Article Publicly Available

Daniel P. Otto
Daniel P. Otto is a Postdoctoral Researcher from the Catalysis and Synthesis Research Group, Chemical Resource Beneficiation Research Focus Area, Faculty of Natural Sciences, North-West University, South Africa. He completed part of his postdoctoral study working at the School of Pharmacy at the University of Wisconsin. His research interests are, in general, nanotechnological pharmaceutics and, in particular, designing drug delivery systems for controlled and targeted delivery using LbL self-assembly. He is the coauthor of 10 papers in the field of nanosized drug delivery systems.
and Melgardt M. de Villiers
Melgardt M. de Villiers is a Professor at the University of Wisconsin School of Pharmacy. His current research is focused on determining the pharmaceutical science involved in developing an understanding of the pharmaceutics, engineering, and materials sciences principles underlying enhanced drug delivery technologies. Several of his publications have been related to layer-by-layer nanocoating and to solid-state nanoparticle properties of drugs and excipients. Dr. De Villiers is the associate editor of AAPS PharmSciTech, an AAPS fellow and the recipient of the Outstanding Professor in the College of Health Sciences at the University of Louisiana at Monroe.

Published/Copyright: February 16, 2013

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information

Received: 2012-12-3

Accepted: 2013-1-2

Published Online: 2013-02-16

Published in Print: 2013-04-01

Articles in the same Issue

Keywords for this article

nano-enabled drug delivery; nanoparticle; nanotechnology; physicochemical properties